The diagnosis of prostate cancer dissemination;Métodos diagnósticos de la diseminación prostática

Archivos Espanoles de Urologia

Volumn 59, Issue 10, 2006, Pages 1011-1020

  Lorente Garín, José Antonio ^a   Gelabert Mas, Antoni ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Diagnostic methods; Disemination; Prostate cancer

Indexed keywords

ARTICLE; BONE TUMOR; DIAGNOSTIC IMAGING; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; PATHOLOGY; PROSTATE TUMOR;

BONE NEOPLASMS; DIAGNOSTIC IMAGING; HUMANS; LYMPHATIC METASTASIS; MALE; PROSTATIC NEOPLASMS;

EID: 33846491714     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. HUNCHAREK, M.; MUSCAT, J.: "Serum prostate specific antigen as a predictor of the staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer". Abdom. Imaging., 21: 364, 1996.
2. YU, K.K.; HRICAK, H.: "Neoplasms of the prostate gland. Clinical Urography". Second Edition. Saunders Ed. 2000.
3. OYEN, R.H.; VAN POPPEL, H.P.; AMEYE, F.E. y cols.: "Lymph node staging of localized prostate carcinoma with CT and CT-guided fine-needle aspiration biopsy: Prospective study of 285 patients". Radiology, 190: 315, 1994.
4. LANGLOTZ, C.; SCHNALL, M.; POLLACK, H.: "Staging of prostatic cancer: Accuracy of MR imaging". Radiology, 194: 645, 1995.
5. SELTZER, M.A.; BARBARIE, Z.; BELLDEGRUN, A. y cols.: "Comparison of helical computerized tomography, positron emisión tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse alter treatment for localized prostate cancer". J. Urol., 162: 1322, 1999.
6. DE JONG, I.J.; PRIUM, J.; ELSINGA, RH. y cols.: "Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-Choline PET". J. Nucl. Med., 44: 331, 2003.
7. LANGE, P.H.: "ProstaScint scan for staging prostate cancer". Urology, 57: 402, 2001.
8. EDELSTYN, G.A.; GILLESPIE, P.J.; GREBELL, F.S.: "The radiological demonstration of osseous metastases: experimental observation". Clin. Radiol., 18: 158, 1967.
9. BORAK, J.: "Relationship between the clinical and roentgenological findings in bone metastases". Surg. Gynecol. Obst., 75: 599, 1942.
10. LOTE, K.; WALLOE, A.; BJERSAND, A.: "Bone metastasis. Prognosis, diagnosis and treatment". Acta Radiol. Oncol., 25: 227, 1986.
11. HOVSEPIAN, J.A.; BYAR, D.P.: "Quantitative radiology for staging and prognosis of patients with advanced prostatic carcinoma". Urology, 14: 145, 1979.
12. MOORE, S.G.; DAWSON, K.L.: "Red and yellow marrow in the femur: age related changes in appearance at MR imaging". Radiology, 175: 219, 1990.
13. SIGIMURA, K.; YAMASAKI, K.; KITAGAKI, H.: "Bone marrow diseases of the spine: differentiation with T1 and T2 relaxation times in MR imaging". Radiology, 165: 541, 1987.
14. BAFER, L.L.; GOODMAN,S.B.; PERKESH, I. y cols.: "Benign versus pathologic compression fractures of vertebral bodies: assessment with conventional spin echo, chemical shift and STIR MR imaging". Radiology, 174: 495, 1990.
15. DAFFNER, R.H.; LUPETIN, A.R.; DASH, J. y cols.: "MRI in the detection of malignant infiltration of bone marrow". AJR, 146: 353, 1986.
16. MEHTA, R.C.; WILSON, M.A.; PERTMAN, S.B.: "False negative bone scan in extensive metastatic disease: CT and MRI findings". JCAT, 13: 717, 1989.
17. AVRAHAMI, E.; TADMOR, R.; DALLY, O. y cols.: "Early demonstration of spinal metastases in patients with normal radiography and CT and radionuclide bone scan". JCAT, 13: 598, 1989.
18. WETZEL, L.H.; ENGELBRECHT, D.E.; BAXTER, K.G. y cols.: "Comparison of MR imaging and bone scintigraphy for detection and evaluation of osseous spinal metastases". Radiology, 177: 371, 1990.
19. FUJI, Y.; HIGASHI, Y.; OWADA, F. y cols.: "Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone". Br. J. Urol., 75: 54, 1995.
20. ECKELMAN, W.; RICHARDS, P.: "Instant 99mTc-DTPA". J. Nucl. Med., 11: 761, 1970.
21. CITRIN, D.L.; BESSENT, R.G.; McGINLEY, E. y cols.: "Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumours". J. Nucl. Med., 16: 886, 1975.
22. FOGELMAN, I.; CITRIN, D.L.; McKILLOP, J.H. y cols.: "A clinical comparison of 99mTc-HEDP and 99mTc-MDP in the detection of bone metastases: concise communication". J. Nucl. Med., 20: 98, 1979.
23. MERRICK, M.V.: "Review article. Bone scanning". Br. J. Radiol., 48: 327, 1975.
24. HARDOFF, R.; FRONT, D.: "The value of delayed bone scintigraphy". Clin. Nucl. Med., 3: 39, 1978.
25. SCHUTTLE, H.E.: "Some special views in bone scanning". Clin. Nucl. Med., 5: 172, 1980.
26. BAHK, Y.W.; KIM, O.K.; CHUNG, S.K. y cols.: "Pinhole collimator scintigraphy in differential diagnosis of metastasis, fracture and infections of the spine". J. Nucl. Med., 28: 447, 1987.
27. SHIH, W.J.; MAGOUN, S.; STRIPP, V. y cols.: "Volume three-dimensional display of 99mTc-HMDP skull, cervical vertebral, thoracic vertebral, lumbar vertebral, and/or pelvic SPECT images by triple head camera". J. Nucl. Med., 33: 913, 1991.
28. O'MARA, R.E.: "Skeletal scanning in neoplastic disease". Cancer, 37: 480, 1986.
29. GALASKO, C.S.B.: "Mechanisms of lytic and blastic metastatic disease of bone". Clin. Orthop. Rel. Res., 12: 20, 1982.
30. MILCH, R.A.; CHANGUS, G.W.: "Response of bone to tumour invasion". Cancer, 9: 340, 1956.
31. GALASKO, C.S.B.: "Mechanism of uptake of bone imaging isotopes by skeletal metastases". Clin. Nucl. Med., 5: 565, 1980.
32. GALASKO, C.S.B.: "The pathological basis for skeletal scintigraphy". J. Bone Joint Surg., 57: 353, 1975.
33. FOGELMAN, I.; McKILLOP, J.H.; GREIG, W.R. y cols.: "Absent kidney sign associated with symmetrical and uniformly increased uptake of tracer by skeleton". Eur. J. Nucl. Med., 2: 257, 1977.
34. DUNCKER, C.M.; CARRIÓ, I.; BERNÁ, L.L.: "Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer". J. Nucl. Med., 31: 1450, 1991.
35. SANAL, S.M.; FLICKINGER, F.W.; CAUDELL, M.J. y cols.: "Detection of bone marrow involvement in breast cancer with magnetic resonance imaging". J. Clin. Oncol., 12: 1415, 1994.
36. KOBER, B.; HERMANN, H.J.; WETZEL, E.: "Cold lesions in bone scintigraphy". Fortschr. Roentgenstr., 131: 545, 1979.
37. CORCORAN, R.J.; THRALL, J.H.; KYLE, R.W.: "Solitary abnormalities in bone scan of patients with extraosseous malignancies". Radiology, 121: 663, 1976.
38. RAPPAPORT, A.H.; HOFFER, P.B.; GENANT, H.K. y cols.: "Unifocal bone findings by scintigraphy. Clinical significance in patients with know primary cancer". West J. Med., 129: 188, 1978.
39. BROWN, M.L.: "Significance of the solitary lesion in paediatric bone scanning". J. Nucl. Med., 24: 114, 1987.
40. YAXAWA, Y.; FRASSICA, F.J.; CHAO, E.Y.S.: "Metastatic bone disease: a study of the surgical treatment of 166 pathologic humeral and femoral fractures". Clin. Orthop., 25: 213, 1980.
41. SCHURMANS, J.R.; BLIJENBERG, B.G.; MICKISH, G.H. y cols.: "Spontaneous remission of a body metastasis in prostatic adenocarcinoma". J. Urol., 155: 653, 1996.
42. SOLOWAY, M.S.; HARDEMAN, S.W.; HICKEY, D. y cols.: "Stratfication of patients with prostate cancer based on extent of disease on initial bone scan". Cancer, 61: 195, 1988.
43. YAMASHITA, K.; DENNO, K.; UEDA, T. y cols.: "Prognostic significance of bone metastases in patients with metastatic prostate cancer". Cancer, 71: 1297, 1993.
44. CHER, M.L.; BIANCO, F.J.; LAM, J.S. y cols.: "Limited role of radionuclide bone scintigraphy patients with prostate specific antigen elevations after radical prostatectomy". J. Urol., 160: 1387, 1998.
45. EFFERT, P.J.; BARES, R.; HANDT, S. y cols.: "Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose". J. Urol., 155: 994, 1996.
46. SHREVE, P.D.; GOSSMAN, H.B.; GROSS, M.D. y cols.: "Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-F18-fluoro-D- glucose". Radiology, 199: 751, 1996.
47. DE JONG, I.J.; PRIUM, J.; ELSINGA, P.H. y cols.: "Visualization of prostate cancer with 11C-Choline positron emission tomography". Eur. Urol., 42: 18, 2002.
48. ITO, Y.; OKUYAMA, S.; SUZUKI, M.: "Bone marrow scintigraphy in the early diagnosis of experimental metastatic carcinoma". Cancer, 31: 1222, 1973.
49. HADDOCK, G.; GRAY, H.W.; McKILLOP, J.H. y cols.: "99mTc-Nanocolloid bone marrow sintigraphy in prostate cancer". Br. J. Urol., 63: 497, 1989.
50. GLEAVE, M.E.; COUPLAND, D.; DRACHENBERG, D. y cols.: "Ability of serum prostate specific antigen levels to predict normal bone scan in patients with newly diagnosed prostate cancer". Urology, 47: 708, 1996.
51. PUPPO, P.; PERACHINO, M.: "New markers of bone metastasis from prostate cancer: a significant saving". European Urology Today, Personal Communications, 8, 1995.
52. MOROTE, J.; RUIBAL, A.; PASCUAL, C.: "Bone marrow prostatic specific antigen and prostatic acid phosphatase levels: are they helpful in staging prostate cancer?", J. Urol., 137: 891, 1987.
53. DEFTOS, L.J.: "Bone protein and peptide assays in the diagnosis and management of skeletal disease". Clin. Chem., 37: 1143, 1991.
54. CHYBOWSKI, F.M.; KELLER, J.J.; BERGSTRALH, E.J. y cols.: "Predicting radionuclide bone scan findings in patients with newly diagnosed untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters". J. Urol., 145: 313, 1991.
55. OESTERLING, J.E.; MARTIN, S.K.; BERGSTRALH, E.J. y cols.: "The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer". JAMA, 269: 57, 1993.
56. LORENTE, J.A.; VALENZUELA, H.; MOROTE, J. y cols.: "Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients". Eur. J. Nucl. Med., 26: 625, 1999.